Frequency of HBV, HCV and HIV Infections and Determination of HCV Genotype Distribution in People who Inject Drugs
Journal Title: Viral Hepatitis Journal - Year 2021, Vol 27, Issue 1
Abstract
Objectives: The aim of this study was to determine the frequency of blood-borne infections [hepatitis B virus (HBV), HCV, and human immunodeficiency virus (HIV)] and the genotype distribution retrospectively in people who inject drugs (PWID). Materials and Methods: A total of 150 PWID were investigated retrospectively. HBV, HCV, HIV serologies and viral load information were recorded. Results: The mean age was 27.0±4.89 and 13 (8.7%) patients were female. One hundred and twenty six (84.0%) patients had shared injectors at least once in their lives. Anti-HCV positivity was detected in 91 (60.6%) of 150 patients, hepatitis B surface antigen positivity in 3 (2.0%) and anti-HIV positivity in 1 patient. HCV-RNA was detected in 61 of the patients with anti-HCV positivity and 48 (67.6%) of them were positive for HCV-RNA. Genotype was studied in 38 patients with HCV-RNA positivity. Genotype 1a was detected in 20 patients, genotype 3a in 12 patients, genotype 4c/d in 5 patients and 2b in 1 patient. Conclusion: In PWID, HCV infection was found to be in high ratio in PWIDs and the most common HCV genotype was 1a. It was concluded that injector sharing caused infectious diseases in PWID and that some HCV genotypes were dominant in these patients. Genotype determination will be a guide for individualized treatments in these patients.
Authors and Affiliations
Hüseyin Kara, Dilara İnan, Özgen Özçelik, Ali Erdoğan, Dilek Çolak, Gözde Öngüt
Keywords
Related Articles
- EP ID EP694435
- DOI 10.4274/vhd.galenos.2021.2020-12-6
- Views 78
- Downloads 0
Genotype Distributions and Hepatitis B Coinfection in Hepatitis C Patients at a University Hospital
Objectives: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Comorbidity with the hepatitis B virus (HBV) leads to progressive fibrosis and severe liver disease. Our study aimed to determine H...
Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection
Objectives: This study aimed to investigate the effect of treatment with direct-acting antivirals (DAAs) on the virological response and on the some parameters used to evaluate liver function in cases with chronic liver...
Genotype Distribution of Hepatitis C Virus and Demographic Features of The Patients in The Province of Karabük
Objectives: It was aimed to determine the distribution of hepatitis C virus (HCV) genotypes among patients who had HCV infection, and to identify the demographic characteristics of these patients. Materials and Methods:...
The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
Objectives: Directly-acting anti-viral agents for the treatment of hepatitis C have been revolutionised. In the meantime, hepatitis C patients with sustained virologic response (SVR) achieved with previous treatments hav...
The Evaluation of a Hundred Eleven Adult Patients with Acute Hepatitis
Objectives: We aimed to evaluate the etiological, epidemiological and laboratory characteristics of adult patients admitted to our hospital with acute hepatitis. Materials and Methods: The patients with alanine aminotra...